5,213
Views
27
CrossRef citations to date
0
Altmetric
Report

PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer

ORCID Icon, , , ORCID Icon, , , , ORCID Icon, ORCID Icon & show all
Pages 947-962 | Received 11 Nov 2016, Accepted 02 Oct 2017, Published online: 31 May 2018

References

  • Blanco-Aparicio C, Renner O, Leal JFM, et al. PTEN, more than the AKT pathway. Carcinogenesis. 2007;28:1379–1386. doi:10.1093/carcin/bgm052. PMID:17341655
  • Yanagi S, Kishimoto H, Kawahara K, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. The Journal of Clinical Investigation 2007;117:2929–2940. doi:10.1172/JCI31854. PMID:17909629
  • Dave V, Wert SE, Tanner T, et al. Conditional deletion of Pten causes bronchiolar hyperplasia. American Journal of Respiratory Cell and Molecular Biology. 2008;38:337–345. doi:10.1165/rcmb.2007-0182OC. PMID:17921358
  • Shaykhiev R, Otaki F, Bonsu Y, et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2011;68:877–892. doi:10.1007/s00018-010-0500-x. PMID:20820852.
  • Forgacs E, Biesterveld EJ, Sekido Y, et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene. 1998;17:1557–1565. doi:10.1038/sj.onc.1202070. PMID:9794233
  • Fumarola C, Bonelli MA, Petronini PG, et al. Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol. 2014;90:197–207. doi:10.1016/j.bcp.2014.05.011. PMID:24863259
  • Sarris EG, Saif MW, Syrigos KN. The Biological role of PI3K pathway in lung cancer. Pharmaceuticals. 2012;5:1236–1264. doi:10.3390/ph5111236. PMID:24281308
  • Marsit CJ, Zheng S, Aldape K, et al. PTEN expression in non-small-cell lung cancer: Evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Human Pathol. 2005;36:768–776. doi:10.1016/j.humpath.2005.05.006. PMID:16084946
  • Tang JM, He QY, Guo RX, et al. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer. 2006;51:181–191. doi:10.1016/j.lungcan.2005.10.003. PMID:16324768
  • Cetin Z, Ozbilim G, Erdogan A, et al. Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR. Medical Oncol. 2010;27:853–860. doi:10.1007/s12032-009-9296-7.
  • Yanagawa N, Leduc C, Kohler D, et al. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma. J Thorac Oncol. 2012;7:1513–1521. doi:10.1097/JTO.0b013e3182641d4f. PMID:22982652
  • Panagiotou I, Tsiambas E, Lazaris AC, et al. PTEN expression in non small cell lung carcinoma based on digitized image analysis. J Buon. 2012;17:719–723. PMID:23335531
  • Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nature Reviews Molecular Cell Biol. 2012;13:283–296. PMID:22473468
  • Sos ML, Koker M, Weir BA, et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 2009;69:3256–3261. doi:10.1158/0008-5472.CAN-08-4055. PMID:19351834
  • Vazquez F, Grossman SR, Takahashi Y, et al. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem. 2001;276:48627–48630. doi:10.1074/jbc.C100556200. PMID:11707428
  • Rahdar M, Inoue T, Meyer T, et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. P Natl Acad Sci USA. 2009;106:480–485. doi:10.1073/pnas.0811212106.
  • Odriozola L, Singh G, Hoang T, et al. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem. 2007;282:23306–23315. doi:10.1074/jbc.M611240200. PMID:17565999
  • Nguyen HN, Yang JM, Miyamoto T, et al. Opening the conformation is a master switch for the dual localization and phosphatase activity of PTEN. Sci Rep-Uk. 2015;5:12600. doi:10.1038/srep12600. PMID:26216063.
  • Shen WH, Balajee AS, Wang J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007;128:157–170. doi:10.1016/j.cell.2006.11.042. PMID:17218262
  • Kang X, Song C, Du X, et al. PTEN stabilizes TOP2A and regulates the DNA decatenation. Sci Rep. 2015;5:17873. doi:10.1038/srep17873.
  • Feng JW, Liang J, Li JJ, et al. PTEN Controls the DNA Replication Process through MCM2 in Response to Replicative Stress. Cell Reports. 2015;13:1295–303. doi:10.1016/j.celrep.2015.10.016. PMID:26549452
  • Choi BH, Chen Y, Dai W. Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation. Cell Cycle. 2013;12:3442–3447. doi:10.4161/cc.26465. PMID:24047694
  • Chen JH, Zhang P, Chen WD, et al. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells. Autophagy. 2015;11:239–252. doi:10.1080/15548627.2015.1009767. PMID:25701194
  • Ming M, Feng L, Shea CR, et al. PTEN positively regulates UVB-induced DNA damage repair. Cancer Res. 2011;71:5287–5295. doi:10.1158/0008-5472.CAN-10-4614. PMID:21771908
  • Vuono EA, Mukherjee A, Vierra DA, et al. The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair. Sci Rep. 2016;6:36439. doi:10.1038/srep36439. PMID:27819275
  • Guan J, Zhao Q, Mao W. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation. Biochim Biophys Acta. 2016;1863:3106–3115. doi:10.1016/j.bbamcr.2016.10.003. PMID:27741411
  • Gu TT, Zhang Z, Wang JL, et al. CREB Is a Novel Nuclear Target of PTEN Phosphatase. Cancer Res. 2011;71:2821–2825. doi:10.1158/0008-5472.CAN-10-3399. PMID:21385900
  • Horita H, Wysoczynski CL, Walker LA, et al. Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation. Nat Commun. 2016;7:10830. doi:10.1038/ncomms10830. PMID:26940659
  • Lin MC, Liu YC, Tam MF, et al. PTEN interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity. Biochem J. 2012;441:367–377. doi:10.1042/BJ20111257. PMID:21883094
  • Palian BM, Rohira AD, Johnson SAS, et al. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism. Plos Genet. 2014;10(12):e1004789. doi:10.1371/journal.pgen.1004789. PMID:25502566
  • Fan C, He L, Kapoor A, et al. PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer. 2009;8:98. doi:10.1186/1476-4598-8-98. PMID:19903340
  • Chen ZH, Zhu M, Yang J, et al. PTEN interacts with histone H1 and controls chromatin condensation. Cell Reports. 2014;8:2003–2014. doi:10.1016/j.celrep.2014.08.008. PMID:25199838
  • Ginn-Pease ME, Eng C. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G(0)-G(1) in MCF-7 cells. Cancer Res. 2003;63:282–286. PMID:12543774
  • Chung JH, Ostrowski MC, Romigh T, et al. The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet. 2006;15:2553–2559. doi:10.1093/hmg/ddl177. PMID:16849370
  • Jacob AI, Romigh T, Waite KA, et al. Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma research. 2009;19:203–210. doi:10.1097/CMR.0b013e32832ccd6e. PMID:19478684
  • Howitt J, Low LH, Putz U, et al. Ndfip1 represses cell proliferation by controlling Pten localization and signaling specificity. J Mol Cell Biol. 2015;7:119–131. doi:10.1093/jmcb/mjv020. PMID:25801959
  • Kim SJ, Lee HW, Baek JH, et al. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer. Oncogene. 2016;35:251–260. doi:10.1038/onc.2015.80. PMID:25823029
  • Choi BH, Pagano M, Dai W. Plk1 Protein Phosphorylates Phosphatase and Tensin Homolog (PTEN) and Regulates Its Mitotic Activity during the Cell Cycle. J Biol Chem. 2014;289:14066–14074. doi:10.1074/jbc.M114.558155. PMID:24706748
  • Vazquez F, Ramaswamy S, Nakamura N, et al. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol. 2000;20:5010–5018. doi:10.1128/MCB.20.14.5010-5018.2000. PMID:10866658
  • Pathak RR, Grover A, Malaney P, et al. Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung. J Biol Chem. 2013;288:29821–29835. doi:10.1074/jbc.M113.481523. PMID:23963458
  • Terzidis A, Sergentanis TN, Antonopoulos G, et al. Elevated serum leptin levels: a risk factor for non-small-cell lung cancer? Oncology. 2009;76:19–25. doi:10.1159/000177952. PMID:19033693
  • Song C-H, Liao J, Deng Z-H, et al. Is leptin a predictive factor in patients with lung cancer? Clinical Biochemistry. 2014;47:230–232. doi:10.1016/j.clinbiochem.2013.12.003. PMID:24355691
  • Ning K, Miller LC, Laidlaw HA, et al.. A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO Journal. 2006;25:2377–2387. doi:10.1038/sj.emboj.7601118. PMID:16675953
  • Nguyen HN, Afkari Y, Senoo H, et al. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Oncogene. 2014;33:5688–5696. doi:10.1038/onc.2013.507. PMID:24292679
  • Nguyen HN, Yang JM, Afkari Y, et al. Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities. P Natl Acad Sci USA. 2014;111:E2684–E2693. doi:10.1073/pnas.1409433111.
  • Nguyen HN, Yang JM, Rahdar M, et al. A new class of cancer-associated PTEN mutations defined by membrane translocation defects. Oncogene. 2015;34:3737–3743. doi:10.1038/onc.2014.293. PMID:25263454
  • Stumpf M, Blokzijl-Franke S, den Hertog J. Fine-tuning of Pten localization and phosphatase activity is essential for zebrafish angiogenesis. Plos One. 2016;11(5):e0154771. doi:10.1371/journal.pone.0154771.
  • Sun H, Lesche R, Li DM, et al.. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999;96:6199–6204. doi:10.1073/pnas.96.11.6199. PMID:10339565
  • Myers MP, Pass I, Batty IH, et al.. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A. 1998;95:13513–13518. doi:10.1073/pnas.95.23.13513. PMID:9811831
  • Gil A, Andres-Pons A, Fernandez E, et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell. 2006;17:4002–4013. doi:10.1091/mbc.E06-05-0380. PMID:16807353
  • Chung JH, Ginn-Pease ME, Eng C. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res. 2005;65:4108–4116. doi:10.1158/0008-5472.CAN-05-0124. PMID:15899801
  • Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: Exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43:D805–D811. doi:10.1093/nar/gku1075. PMID:25355519
  • Rankin SL, Guy CS, Mearow KM. PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1. Biochem Bioph Res Co. 2009;379:721–725. doi:10.1016/j.bbrc.2008.12.075.
  • Bassi C, Ho J, Srikumar T, et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science. 2013;341:395–399. doi:10.1126/science.1236188. PMID:23888040
  • Chang CJ, Mulholland DJ, Valamehr B, et al. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol. 2008;28:3281–3289. doi:10.1128/MCB.00310-08. PMID:18332125
  • He JX, Kang X, Yin YX, et al. PTEN regulates DNA replication progression and stalled fork recovery. Nat Commun. 2015;6:7620. doi:10.1038/ncomms8620.
  • Wang GX, Li Y, Wang P, et al. PTEN regulates RPA1 and protects DNA replication forks. Cell Res. 2015;25:1189–1204. doi:10.1038/cr.2015.115. PMID:26403191
  • Ming M, He YY. PTEN in DNA damage repair. Cancer Lett. 2012;319(2):125–129. doi:10.1016/j.canlet.2012.01.003.
  • Gong LL, Govan JM, Evans EB, et al. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure. Cell Cycle. 2015;14:2323–2332. doi:10.1080/15384101.2015.1044174. PMID:25946202
  • Misra S, Mukherjee A, Karmakar P. Phosphorylation of PTEN at STT motif is associated with DNA damage response. Mutat Res-Fund Mol M. 2014;770:112–119. doi:10.1016/j.mrfmmm.2014.08.008.
  • Trotman LC, Wang X, Alimonti A, et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007;128:141–156. doi:10.1016/j.cell.2006.11.040. PMID:17218261
  • Lee MS, Jeong MH, Lee HW, et al. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun. 2015;6:7769. doi:10.1038/ncomms8769. PMID:26183061
  • Kechagioglou P, Papi RM, Provatopoulou X, et al. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Res. 2014;34:1387–1400. PMID:24596386
  • Nakahata S, Ichikawa T, Maneesaay P, et al. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393. doi:10.1038/ncomms4393.
  • Yang Z, Yuan XG, Chen J, et al. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation. Clin Res Hepatol Gas. 2013;37:72–79. doi:10.1016/j.clinre.2012.03.002.
  • Roy D, Dittmer DP. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and kaposi's sarcoma. Am J Pathol. 2011;179:2108–2119. doi:10.1016/j.ajpath.2011.06.017. PMID:21819957
  • Lee EJ, Kim N, Kang KH, et al. Phosphorylation/inactivation of PTEN by Akt-independent PI3K signaling in retinal pigment epithelium. Biochem Bioph Res Co. 2011;414:384–389. doi:10.1016/j.bbrc.2011.09.083.
  • Hua F, Ha TZ, Ma J, et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol. 2007;178:7317–7324. doi:10.4049/jimmunol.178.11.7317. PMID:17513782
  • Horita H, Furgeson SB, Ostriker A, et al. Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension. J Am Heart Assoc. 2013;2(3):e000188. doi:10.1161/JAHA.113.000188. PMID:23727701
  • Papa A, Wan L, Bonora M, et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell. 2014;157:595–610. doi:10.1016/j.cell.2014.03.027. PMID:24766807
  • Malaney P, Uversky VN, Dave V. PTEN proteoforms in biology and disease. Cell Mol Life Sci. 2017;74:2783–2794. doi:10.1007/s00018-017-2500-6. PMID:28289760
  • Dillon LM, Miller TW. Therapeutic targeting of cancers with loss of PTEN function. Current drug targets. 2014;15:65–79. doi:10.2174/1389450114666140106100909. PMID:24387334
  • Nair JS, Sheikh T, Ho AL, et al. PTEN regulates sensitivity of melanoma cells to RO4929097, the gamma-secretase inhibitor. Anticancer Res. 2013;33:1307–1316. PMID:23564767
  • Peng WY, Chen JQ, Liu CW, et al. Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016;6:202–216. doi:10.1158/2159-8290.CD-15-0283. PMID:26645196
  • Jing W, Li M, Zhang Y, et al. PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. OncoTargets and Therapy. 2016;9:489–502. doi:10.2147/OTT.S94993. PMID:26889087
  • Mendes-Pereira AM, Martin SA, Brough R, et al. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. Embo Mol Med 2009;1:315–322. doi:10.1002/emmm.200900041. PMID:20049735
  • Ni J, Liu Q, Xie S, et al. Functional characterization of an isoform-selective inhibitor of PI3K-p110beta as a potential anticancer agent. Cancer Discov. 2012;2:425–433. doi:10.1158/2159-8290.CD-12-0003. PMID:22588880
  • Edgar KA, Wallin JJ, Berry M, et al. Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors. Cancer Res 2010; 70:1164–1172. doi:10.1158/0008-5472.CAN-09-2525. PMID:20103642
  • Chen H, Mei L, Zhou L, et al. PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts. Journal of Neuro-Oncol. 2011;104:155–167. doi:10.1007/s11060-010-0492-2. PMID:21188471
  • Ramaswamy S, Nakamura N, Vazquez F, et al. Regulation of G(1) progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. P Natl Acad Sci USA. 1999;96:2110–2115. doi:10.1073/pnas.96.5.2110.
  • Geng Y, Eaton EN, Picon M, et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 1996;12:1173–1180. PMID:8649818
  • Tetsu O, McCormick F. beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426. doi:10.1038/18884. PMID:10201372
  • Neuman E, Flemington EK, Sellers WR, et al. Transcription of the E2f-1 gene is rendered cell-cycle dependent by E2f DNA-binding sites within its promoter. Mol Cell Biol. 1994;14:6607–6615. doi:10.1128/MCB.14.10.6607. PMID:7935380
  • Wang S, Nath N, Fusaro G, et al. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol. 1999;19:7447–7460. doi:10.1128/MCB.19.11.7447. PMID:10523633
  • Rizwani W, Schaal C, Kunigal S, et al. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. Plos One. 2014;9(7):e100888. doi:10.1371/journal.pone.0100888.
  • Nam HS, Benezra R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell. 2009;5:515–526. doi:10.1016/j.stem.2009.08.017. PMID:19896442
  • Ho SN, Hunt HD, Horton RM, et al. Site-directed mutagenesis by overlap extension using the polymerase chain-reaction. Gene. 1989;77:51–59. doi:10.1016/0378-1119(89)90358-2. PMID:2744487
  • Boussif O, Lezoualch F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo – polyethylenimine. P Natl Acad Sci USA. 1995;92:7297–7301. doi:10.1073/pnas.92.16.7297.
  • V D, Childs T, Whitsett JA. Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells. J Biol Chem. 2004;279:34578–34588. doi:10.1074/jbc.M404296200. PMID:15173172
  • Brunner E, Ahrens CH, Mohanty S, et al. A high-quality catalog of the Drosophila melanogaster proteome. Nature Biotechnology. 2007;25:576–583. doi:10.1038/nbt1300. PMID:17450130
  • Hoaglin DC, Iglewicz B, Tukey JW. Performance of some resistant rules for outlier labeling. J Am Stat Assoc. 1986;81:991–999. doi:10.1080/01621459.1986.10478363.
  • Hoaglin DC, Iglewicz B. Fine-tuning some resistant rules for outlier labeling. J Am Stat Assoc. 1987;82:1147–1149. doi:10.1080/01621459.1987. PMID:10478551.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.